| Year |
Citation |
Score |
| 2024 |
Lewis MR, Schaedler AW, Ho KV, Golzy M, Mathur A, Pun M, Gallazzi F, Watkinson LD, Carmack TL, Sikligar K, Anderson CJ, Smith CJ. Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen. Nuclear Medicine and Biology. 108938. PMID 39032262 DOI: 10.1016/j.nucmedbio.2024.108938 |
0.783 |
|
| 2022 |
Mandell JB, Douglas N, Ukani V, Beumer JH, Guo J, Payne J, Newman R, Mancinelli L, Intini G, Anderson CJ, Watters R, Weiss K. Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper. Sarcoma. 2022: 7157507. PMID 35125923 DOI: 10.1155/2022/7157507 |
0.389 |
|
| 2021 |
Bellavia MC, Nyiranshuti L, Latoche JD, Ho KV, Fecek RJ, Taylor JL, Day KE, Nigam S, Pun M, Gallazzi F, Edinger RS, Storkus WJ, Patel RB, Anderson CJ. PET Imaging of VLA-4 in a New BRAF Mouse Model of Melanoma. Molecular Imaging and Biology. PMID 34694528 DOI: 10.1007/s11307-021-01666-1 |
0.416 |
|
| 2021 |
Mattila JT, Beaino W, White AG, Nyiranshuti L, Maiello P, Tomko J, Frye LJ, Fillmore D, Scanga CA, Lin PL, Flynn JL, Anderson CJ. Retention of Cu-FLFLF, a Formyl Peptide Receptor 1-Specific PET Probe, Correlates with Macrophage and Neutrophil Abundance in Lung Granulomas from Cynomolgus Macaques. Acs Infectious Diseases. PMID 34255474 DOI: 10.1021/acsinfecdis.0c00826 |
0.342 |
|
| 2020 |
Perkins LA, Nyiranshuti L, Little-Ihrig L, Latoche JD, Day KE, Zhu Q, Tavakoli S, Sundd P, Novelli EM, Anderson CJ. Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice. Blood Advances. 4: 4102-4112. PMID 32882004 DOI: 10.1182/Bloodadvances.2020002642 |
0.461 |
|
| 2020 |
Haddad J, Latoche JD, Nigam S, Bellavia MC, Day KE, Zhu Q, Edwards WB, Anderson CJ, Tavakoli S. Molecular Imaging of Very Late Antigen-4 (VLA-4) in Acute Lung Injury. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32680928 DOI: 10.2967/Jnumed.120.242347 |
0.425 |
|
| 2020 |
Mandell JB, Douglas N, Ukani V, Anderson C, Beumer J, Watters R, Weiss K. Abstract 345: Altered ALDH1A1 expression and cellular copper levels between low and highly metastatic osteosarcoma provides a case for novel repurposing of disulfiram Tumor Biology. DOI: 10.1158/1538-7445.Am2020-345 |
0.347 |
|
| 2019 |
Nigam S, McCarl L, Kumar R, Edinger RS, Kurland BF, Anderson CJ, Panigrahy A, Kohanbash G, Edwards WB. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody. Molecular Imaging and Biology. PMID 31529407 DOI: 10.1007/S11307-019-01427-1 |
0.344 |
|
| 2019 |
Ling X, Latoche JD, Choy CJ, Kurland BF, Laymon CM, Wu Y, Salamacha N, Shen D, Geruntho JJ, Rigatti LH, Windish HP, Langton-Webster B, Berkman CE, Anderson CJ. Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31321650 DOI: 10.1007/S11307-019-01404-8 |
0.311 |
|
| 2019 |
Nigam S, McCarl L, Kumar R, Anderson C, Edwards B, Kohanbash G. TMIC-39. DEVELOPMENT OF CD11b TRACER FOR THE IMMUNE PET IMAGING IN GLIOBLASTOMA MODEL - COULD BE A GAME CHANGER FOR IMMUNOTHERAPY APPROACHES Neuro-Oncology. 21: vi256-vi256. DOI: 10.1093/Neuonc/Noz175.1073 |
0.353 |
|
| 2018 |
Choi J, Beaino W, Fecek R, Fabian K, Laymon CM, Kurland B, Storkus W, Anderson CJ. Combination treatment of VLA-4 targeted radionuclide therapy and immunotherapy in a mouse model of melanoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29959213 DOI: 10.2967/Jnumed.118.209510 |
0.32 |
|
| 2018 |
Tolmachev V, Grönroos TJ, Yim CB, Garousi J, Yue Y, Grimm S, Rajander J, Perols A, Haaparanta-Solin M, Solin O, Ferdani R, Orlova A, Anderson CJ, Karlström AE. Molecular design of radiocopper-labelled Affibody molecules. Scientific Reports. 8: 6542. PMID 29695813 DOI: 10.1038/S41598-018-24785-2 |
0.558 |
|
| 2018 |
Ocak M, Beaino W, White A, Zeng D, Cai Z, Anderson CJ. Cu-Labeled Phosphonate Cross-Bridged Chelator Conjugates of c(RGDyK) for PET/CT Imaging of Osteolytic Bone Metastases. Cancer Biotherapy & Radiopharmaceuticals. 33: 74-83. PMID 29634417 DOI: 10.1089/Cbr.2017.2419 |
0.51 |
|
| 2018 |
Dai L, Jones CM, Chan WTK, Pham TA, Ling X, Gale EM, Rotile NJ, Tai WC, Anderson CJ, Caravan P, Law GL. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. Nature Communications. 9: 857. PMID 29487362 DOI: 10.1038/S41467-018-03315-8 |
0.364 |
|
| 2017 |
Mattila JT, Beaino W, Maiello P, Coleman MT, White AG, Scanga CA, Flynn JL, Anderson CJ. Positron Emission Tomography Imaging of Macaques with Tuberculosis Identifies Temporal Changes in Granuloma Glucose Metabolism and Integrin α4β1-Expressing Immune Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 28592427 DOI: 10.4049/Jimmunol.1700231 |
0.455 |
|
| 2016 |
Gai Y, Sun L, Hui W, Ouyang Q, Anderson CJ, Xiang G, Ma X, Zeng D. New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging. Inorganic Chemistry. PMID 27347690 DOI: 10.1021/Acs.Inorgchem.6B00395 |
0.584 |
|
| 2016 |
Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Research and Treatment. PMID 27097807 DOI: 10.1007/S10549-016-3795-Y |
0.313 |
|
| 2015 |
Cai Z, Mason NS, Anderson CJ, Edwards WB. Synthesis and preliminary evaluation of an (18)F-labeled oleic acid analog for PET imaging of fatty acid uptake and metabolism. Nuclear Medicine and Biology. PMID 26602329 DOI: 10.1016/J.Nucmedbio.2015.08.005 |
0.312 |
|
| 2015 |
Nedrow JR, Latoche JD, Day KE, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26552656 DOI: 10.1007/S11307-015-0908-7 |
0.452 |
|
| 2015 |
Sun L, Gai Y, Anderson CJ, Zeng D. Highly-efficient and versatile fluorous-tagged Cu(i)-catalyzed azide-alkyne cycloaddition ligand for preparing bioconjugates. Chemical Communications (Cambridge, England). PMID 26426419 DOI: 10.1039/c5cc06858d |
0.415 |
|
| 2015 |
Song J, Cai Z, White AG, Jin T, Wang X, Kadayakkara D, Anderson CJ, Ambrose Z, Young WB. Visualization and quantification of simian immunodeficiency virus (SIV)-infected cells using non-invasive molecular imaging. The Journal of General Virology. PMID 26297664 DOI: 10.1099/Jgv.0.000245 |
0.301 |
|
| 2015 |
Cai Z, Li BT, Wong EH, Weisman GR, Anderson CJ. Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. Dalton Transactions (Cambridge, England : 2003). 44: 3945-8. PMID 25645688 DOI: 10.1039/C4Dt03897E |
0.445 |
|
| 2015 |
Lux J, White AG, Chan M, Anderson CJ, Almutairi A. Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases. Theranostics. 5: 277-88. PMID 25553115 DOI: 10.7150/Thno.10904 |
0.316 |
|
| 2014 |
Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. Positron Emission Tomographic Imaging of Copper 64- and Gallium 68-Labeled Chelator Conjugates of the Somatostatin Agonist Tyr(3)-Octreotate. Molecular Imaging. 13: 7290201400020. PMID 28650295 DOI: 10.2310/7290.2014.00020 |
0.441 |
|
| 2014 |
Beaino W, Anderson CJ. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1856-63. PMID 25256059 DOI: 10.2967/jnumed.114.144881 |
0.315 |
|
| 2014 |
Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Molecular Imaging. 13. PMID 25060207 DOI: 10.2310/7290.2014.00020 |
0.697 |
|
| 2014 |
Cai Z, Ouyang Q, Zeng D, Nguyen KN, Modi J, Wang L, White AG, Rogers BE, Xie XQ, Anderson CJ. 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. Journal of Medicinal Chemistry. 57: 6019-29. PMID 24983404 DOI: 10.1021/Jm500416F |
0.769 |
|
| 2014 |
Zeng D, Guo Y, White AG, Cai Z, Modi J, Ferdani R, Anderson CJ. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Molecular Pharmaceutics. 11: 3980-7. PMID 24720806 DOI: 10.1021/Mp500004M |
0.838 |
|
| 2014 |
Banerjee SR, Pullambhatla M, Foss CA, Nimmagadda S, Ferdani R, Anderson CJ, Mease RC, Pomper MG. â¶â´Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer. Journal of Medicinal Chemistry. 57: 2657-69. PMID 24533799 DOI: 10.1021/Jm401921J |
0.559 |
|
| 2014 |
Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 567-77. PMID 24448825 DOI: 10.1007/S11307-013-0717-9 |
0.538 |
|
| 2014 |
Beaino W, Guo Y, Chang AJ, Anderson CJ. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 19: 427-38. PMID 24445997 DOI: 10.1007/S00775-013-1087-0 |
0.824 |
|
| 2014 |
Cai Z, Anderson CJ. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 224-30. PMID 24347474 DOI: 10.1002/Jlcr.3165 |
0.337 |
|
| 2014 |
Zeng D, Ouyang Q, Cai Z, Xie XQ, Anderson CJ. New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides. Chemical Communications (Cambridge, England). 50: 43-5. PMID 24141371 DOI: 10.1039/C3Cc45928D |
0.36 |
|
| 2014 |
Beaino W, Anderson CJ. Abstract 4923: Gallium-68- and Copper-64-labeled LLP2A conjugates for PET-CT imaging of integrin α4β1 in melanoma Cancer Research. 74: 4923-4923. DOI: 10.1158/1538-7445.Am2014-4923 |
0.552 |
|
| 2014 |
White AG, Lux J, Chan M, Anderson CJ, Almutairi A. Polyacrylamide nanogel systems with 64Cu chelating cross-linkers for PET imaging Nuclear Medicine and Biology. 41: 636. DOI: 10.1016/J.Nucmedbio.2014.05.098 |
0.492 |
|
| 2013 |
Guo Y, Parry JJ, Laforest R, Rogers BE, Anderson CJ. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1621-9. PMID 23873478 DOI: 10.2967/Jnumed.112.118539 |
0.816 |
|
| 2013 |
Zeng D, Zeglis BM, Lewis JS, Anderson CJ. The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 829-32. PMID 23616581 DOI: 10.2967/Jnumed.112.115550 |
0.326 |
|
| 2013 |
Soodgupta D, Hurchla MA, Jiang M, Zheleznyak A, Weilbaecher KN, Anderson CJ, Tomasson MH, Shokeen M. Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma. Plos One. 8: e55841. PMID 23409060 DOI: 10.1371/Journal.Pone.0055841 |
0.825 |
|
| 2013 |
Jiang M, Ferdani R, Shokeen M, Anderson CJ. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors. Nuclear Medicine and Biology. 40: 245-51. PMID 23265977 DOI: 10.1016/J.Nucmedbio.2012.10.010 |
0.851 |
|
| 2013 |
Soodgupta D, Hurchla MA, Jiang M, Zheleznyak A, Weilbaecher KN, Anderson CJ, Tomasson MH, Shokeen M. Correction: Very Late Antigen-4 (α4β1Integrin) Targeted PET Imaging of Multiple Myeloma Plos One. 8. DOI: 10.1371/Annotation/8532E291-73D3-461C-810D-0533Ccb1Eba0 |
0.762 |
|
| 2012 |
Guo Y, Ferdani R, Anderson CJ. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjugate Chemistry. 23: 1470-7. PMID 22663248 DOI: 10.1021/Bc300092N |
0.851 |
|
| 2012 |
Shokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz JK, Anderson CJ. Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 779-86. PMID 22496586 DOI: 10.2967/Jnumed.111.100073 |
0.82 |
|
| 2012 |
Ferdani R, Stigers DJ, Fiamengo AL, Wei L, Li BT, Golen JA, Rheingold AL, Weisman GR, Wong EH, Anderson CJ. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Transactions (Cambridge, England : 2003). 41: 1938-50. PMID 22170043 DOI: 10.1039/C1Dt11743B |
0.833 |
|
| 2012 |
Nguyen K, Parry JJ, Rogers BE, Anderson CJ. Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. Nuclear Medicine and Biology. 39: 187-97. PMID 22056254 DOI: 10.1016/J.Nucmedbio.2011.08.006 |
0.808 |
|
| 2012 |
Zheleznyak A, Wadas TJ, Sherman CD, Wilson JM, Kostenuik PJ, Weilbaecher KN, Anderson CJ. Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 500-8. PMID 21853370 DOI: 10.1007/S11307-011-0512-4 |
0.378 |
|
| 2012 |
Shokeen M, Pressly E, Connal L, Liu Y, Hawker CJ, Woodard PK, Anderson CJ, Achilefu S, Welch MJ. Multi-modal in cellulo evaluation of NPR-C targeted C-ANF-peptide and C-ANF-comb nanoparticles Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8233. DOI: 10.1117/12.914991 |
0.58 |
|
| 2012 |
Chang A, Nguyen K, Rogers B, Laforest R, Anderson C. PD-0532 64CU-RADIOLABELED OCTREOTATE AS A THERANOSTIC AGENT FOR CANCER: ROLE OF P53 IN THE THERAPEUTIC RESPONSE Radiotherapy and Oncology. 103: S213. DOI: 10.1016/S0167-8140(12)70871-X |
0.608 |
|
| 2011 |
Bryan JN, Jia F, Mohsin H, Sivaguru G, Anderson CJ, Miller WH, Henry CJ, Lewis MR. Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy. Cancer Biology & Therapy. 11: 1001-7. PMID 21464612 DOI: 10.4161/Cbt.11.12.15528 |
0.443 |
|
| 2011 |
Odendaal AY, Fiamengo AL, Ferdani R, Wadas TJ, Hill DC, Peng Y, Heroux KJ, Golen JA, Rheingold AL, Anderson CJ, Weisman GR, Wong EH. Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes. Inorganic Chemistry. 50: 3078-86. PMID 21381676 DOI: 10.1021/Ic200014W |
0.842 |
|
| 2011 |
Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R, Sherman CD, Achilefu S, Anderson CJ, Rogers BE. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 470-7. PMID 21321264 DOI: 10.2967/Jnumed.110.082826 |
0.733 |
|
| 2011 |
Shokeen M, Pressly ED, Hagooly A, Zheleznyak A, Ramos N, Fiamengo AL, Welch MJ, Hawker CJ, Anderson CJ. Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. Acs Nano. 5: 738-47. PMID 21275414 DOI: 10.1021/Nn102278W |
0.76 |
|
| 2010 |
Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. Cancer Biotherapy & Radiopharmaceuticals. 25: 693-703. PMID 21204764 DOI: 10.1089/Cbr.2010.0820 |
0.324 |
|
| 2010 |
Seo JW, Mahakian LM, Kheirolomoom A, Zhang H, Meares CF, Ferdani R, Anderson CJ, Ferrara KW. Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconjugate Chemistry. 21: 1206-15. PMID 20568726 DOI: 10.1021/Bc100018N |
0.548 |
|
| 2010 |
Stigers DJ, Ferdani R, Weisman GR, Wong EH, Anderson CJ, Golen JA, Moore C, Rheingold AL. A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applications. Dalton Transactions (Cambridge, England : 2003). 39: 1699-701. PMID 20449406 DOI: 10.1039/B920871B |
0.512 |
|
| 2010 |
Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chemical Reviews. 110: 2858-902. PMID 20415480 DOI: 10.1021/Cr900325H |
0.398 |
|
| 2010 |
Anderson CJ, Bulte JW, Chen K, Chen X, Khaw BA, Shokeen M, Wooley KL, VanBrocklin HF. Design of targeted cardiovascular molecular imaging probes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 3S-17S. PMID 20395345 DOI: 10.2967/Jnumed.109.068130 |
0.304 |
|
| 2010 |
Guo Y, Zheleznyak A, Anderson CJ. Relationship between cisplatin, copper-64 radiopharmaceuticals and p53 in the trafficking of 64Cu to the nuclei of tumor cells Nuclear Medicine and Biology. 37: 706. DOI: 10.1016/J.Nucmedbio.2010.04.105 |
0.833 |
|
| 2010 |
Ferdani R, Guo Y, Stigers D, Fiamengo AL, Wei L, Wong EH, Weisman GR, Anderson CJ. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of CB-TE1A1P Nuclear Medicine and Biology. 37: 690. DOI: 10.1016/J.Nucmedbio.2010.04.048 |
0.811 |
|
| 2009 |
Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 Radiopharmaceuticals for Oncologic Imaging. Pet Clinics. 4: 49-67. PMID 27156895 DOI: 10.1016/J.Cpet.2009.04.013 |
0.534 |
|
| 2009 |
Wadas TJ, Deng H, Sprague JE, Zheleznyak A, Weilbaecher KN, Anderson CJ. Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1873-80. PMID 19875645 DOI: 10.2967/Jnumed.109.067140 |
0.704 |
|
| 2009 |
Anderson CJ, Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. Cancer Biotherapy & Radiopharmaceuticals. 24: 379-93. PMID 19694573 DOI: 10.1089/Cbr.2009.0674 |
0.562 |
|
| 2009 |
Barnard PJ, Holland JP, Bayly SR, Wadas TJ, Anderson CJ, Dilworth JR. Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents. Inorganic Chemistry. 48: 7117-26. PMID 19588930 DOI: 10.1021/Ic900307F |
0.45 |
|
| 2009 |
Shokeen M, Anderson CJ. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Accounts of Chemical Research. 42: 832-41. PMID 19530674 DOI: 10.1021/Ar800255Q |
0.415 |
|
| 2009 |
Berezin MY, Guo K, Teng B, Edwards WB, Anderson CJ, Vasalatiy O, Gandjbakhche A, Griffiths GL, Achilefu S. Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye. Journal of the American Chemical Society. 131: 9198-200. PMID 19514722 DOI: 10.1021/Ja903685B |
0.35 |
|
| 2009 |
Hausner SH, Kukis DL, Gagnon MK, Stanecki CE, Ferdani R, Marshall JF, Anderson CJ, Sutcliffe JL. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Molecular Imaging. 8: 111-21. PMID 19397856 DOI: 10.2310/7290.2009.00015 |
0.42 |
|
| 2009 |
Wei L, Ye Y, Wadas TJ, Lewis JS, Welch MJ, Achilefu S, Anderson CJ. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nuclear Medicine and Biology. 36: 277-85. PMID 19324273 DOI: 10.1016/J.Nucmedbio.2008.12.008 |
0.625 |
|
| 2009 |
Denardo SJ, Liu R, Albrecht H, Natarajan A, Sutcliffe JL, Anderson C, Peng L, Ferdani R, Cherry SR, Lam KS. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 625-34. PMID 19289419 DOI: 10.2967/Jnumed.108.056903 |
0.417 |
|
| 2009 |
Almutairi A, Rossin R, Shokeen M, Hagooly A, Ananth A, Capoccia B, Guillaudeu S, Abendschein D, Anderson CJ, Welch MJ, Fréchet JM. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 685-90. PMID 19129498 DOI: 10.1073/Pnas.0811757106 |
0.455 |
|
| 2009 |
Papini G, Alidori S, Lewis JS, Reichert DE, Pellei M, Gioia Lobbia G, Biddlecombe GB, Anderson CJ, Santini C. Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Transactions (Cambridge, England : 2003). 177-84. PMID 19081987 DOI: 10.1039/B808831D |
0.537 |
|
| 2008 |
Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Current Pharmaceutical Design. 14: 2983-98. PMID 18991714 DOI: 10.2174/138161208786404326 |
0.313 |
|
| 2008 |
Wadas TJ, Eiblmaier M, Zheleznyak A, Sherman CD, Ferdani R, Liang K, Achilefu S, Anderson CJ. Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1819-27. PMID 18927338 DOI: 10.2967/Jnumed.108.054502 |
0.578 |
|
| 2008 |
Eiblmaier M, Meyer LA, Watson MA, Fracasso PM, Pike LJ, Anderson CJ. Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1472-9. PMID 18703609 DOI: 10.2967/Jnumed.108.052316 |
0.384 |
|
| 2008 |
Ping Li W, Meyer LA, Capretto DA, Sherman CD, Anderson CJ. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biotherapy & Radiopharmaceuticals. 23: 158-71. PMID 18454685 DOI: 10.1089/Cbr.2007.0444 |
0.486 |
|
| 2008 |
Anderson CJ, Wadas TJ, Wong EH, Weisman GR. Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 52: 185-92. PMID 18043536 |
0.365 |
|
| 2008 |
Edwards WB, Xu B, Akers W, Cheney PP, Liang K, Rogers BE, Anderson CJ, Achilefu S. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjugate Chemistry. 19: 192-200. PMID 18020401 DOI: 10.1021/Bc700291M |
0.699 |
|
| 2008 |
Eiblmaier M, Meyer LA, Anderson CJ. The role of p53 in the trafficking of copper-64 to tumor cell nuclei. Cancer Biology & Therapy. 7: 63-9. PMID 17938576 DOI: 10.4161/Cbt.7.1.5130 |
0.546 |
|
| 2007 |
Lewis JS, Anderson CJ. Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy. Methods in Molecular Biology (Clifton, N.J.). 386: 227-40. PMID 18604948 DOI: 10.1007/978-1-59745-430-8_8 |
0.356 |
|
| 2007 |
Eiblmaier M, Andrews R, Laforest R, Rogers BE, Anderson CJ. Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1390-6. PMID 17631550 DOI: 10.2967/Jnumed.107.039990 |
0.742 |
|
| 2007 |
Heroux KJ, Woodin KS, Tranchemontagne DJ, Widger PC, Southwick E, Wong EH, Weisman GR, Tomellini SA, Wadas TJ, Anderson CJ, Kassel S, Golen JA, Rheingold AL. The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. Dalton Transactions (Cambridge, England : 2003). 2150-62. PMID 17514336 DOI: 10.1039/B702938A |
0.553 |
|
| 2007 |
Sprague JE, Peng Y, Fiamengo AL, Woodin KS, Southwick EA, Weisman GR, Wong EH, Golen JA, Rheingold AL, Anderson CJ. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. Journal of Medicinal Chemistry. 50: 2527-35. PMID 17458949 DOI: 10.1021/Jm070204R |
0.827 |
|
| 2007 |
Parry JJ, Eiblmaier M, Andrews R, Meyer LA, Higashikubo R, Anderson CJ, Rogers BE. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Molecular Imaging. 6: 56-67. PMID 17311765 DOI: 10.2310/7290.2007.00001 |
0.678 |
|
| 2007 |
Sprague JE, Kitaura H, Zou W, Ye Y, Achilefu S, Weilbaecher KN, Teitelbaum SL, Anderson CJ. Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 311-8. PMID 17268030 |
0.599 |
|
| 2007 |
Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper chelation chemistry and its role in copper radiopharmaceuticals. Current Pharmaceutical Design. 13: 3-16. PMID 17266585 DOI: 10.2174/138161207779313768 |
0.473 |
|
| 2006 |
Wadas TJ, Anderson CJ. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nature Protocols. 1: 3062-8. PMID 17406569 DOI: 10.1038/Nprot.2006.431 |
0.462 |
|
| 2006 |
Sprague JE, Li WP, Liang K, Achilefu S, Anderson CJ. In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nuclear Medicine and Biology. 33: 227-37. PMID 16546677 DOI: 10.1016/J.Nucmedbio.2005.10.011 |
0.703 |
|
| 2006 |
Shen X, Boswell CA, Wong EH, Weisman GR, Anderson CJ, Tomellini SA. Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography. Biomedical Chromatography : Bmc. 20: 37-47. PMID 15954159 DOI: 10.1002/Bmc.525 |
0.741 |
|
| 2006 |
Edwards WB, Liang K, Xu B, Anderson CJ, Achlefu S. Synthesis and radiolabeling of a somatostatin analog for multimodal imaging Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6097. DOI: 10.1117/12.648096 |
0.512 |
|
| 2005 |
Bryan JN, Jia F, Mohsin H, Sivaguru G, Miller WH, Anderson CJ, Henry CJ, Lewis MR. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nuclear Medicine and Biology. 32: 851-8. PMID 16253810 DOI: 10.1016/J.Nucmedbio.2005.05.006 |
0.55 |
|
| 2005 |
Yoo J, Reichert DE, Kim J, Anderson CJ, Welch MJ. A potential Dubin-Johnson syndrome imaging agent: synthesis, biodistribution, and microPET imaging. Molecular Imaging. 4: 18-29. PMID 15967123 DOI: 10.1162/15353500200504160 |
0.596 |
|
| 2005 |
Boswell CA, McQuade P, Weisman GR, Wong EH, Anderson CJ. Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS. Nuclear Medicine and Biology. 32: 29-38. PMID 15691659 DOI: 10.1016/J.Nucmedbio.2004.09.004 |
0.725 |
|
| 2005 |
Woodin KS, Heroux KJ, Boswell CA, Wong EH, Weisman GR, Niu W, Tomellini SA, Anderson CJ, Zakharov LN, Rheingold AL. Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: Possible implications for in vivo stability European Journal of Inorganic Chemistry. 4829-4833. DOI: 10.1002/Ejic.200500579 |
0.723 |
|
| 2004 |
Bryan JN, Lewis MR, Henry CJ, Owen NK, Zhang J, Mohsin H, Jia F, Sivaguru G, Anderson CJ. Development of a two-antibody model for the evaluation of copper-64 radioimmunotherapy. Veterinary and Comparative Oncology. 2: 82-90. PMID 19379188 DOI: 10.1111/J.1476-5810.2004.00041.X |
0.446 |
|
| 2004 |
Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8674-82. PMID 15623652 DOI: 10.1158/1078-0432.Ccr-04-1084 |
0.778 |
|
| 2004 |
Sun X, Kim J, Martell AE, Welch MJ, Anderson CJ. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. Nuclear Medicine and Biology. 31: 1051-9. PMID 15607487 DOI: 10.1016/J.Nucmedbio.2004.08.011 |
0.647 |
|
| 2004 |
Sun X, Anderson CJ. Production and applications of copper-64 radiopharmaceuticals. Methods in Enzymology. 386: 237-61. PMID 15120255 DOI: 10.1016/S0076-6879(04)86011-7 |
0.498 |
|
| 2004 |
Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. Journal of Medicinal Chemistry. 47: 1465-74. PMID 14998334 DOI: 10.1021/Jm030383M |
0.774 |
|
| 2004 |
Bryan JN, Mohsin H, Jia F, Siegall CB, Anderson CJ, Miller WH, Henry CJ, Lewis MR. A two-antibody model for copper-64 radioimmunotherapy: biodistributions and tumor dosimetry in a mouse model of cancer Veterinary and Comparative Oncology. 2: 99-99. DOI: 10.1111/J.1476-5810.2004.0045B.X |
0.537 |
|
| 2003 |
Wang M, Caruano AL, Lewis MR, Meyer LA, VanderWaal RP, Anderson CJ. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Research. 63: 6864-9. PMID 14583484 |
0.471 |
|
| 2003 |
Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 1284-92. PMID 12902420 |
0.626 |
|
| 2003 |
Sun X, Wuest M, Kovacs Z, Sherry AD, Motekaitis R, Wang Z, Martell AE, Welch MJ, Anderson CJ. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 8: 217-25. PMID 12459917 DOI: 10.1007/S00775-002-0408-5 |
0.66 |
|
| 2002 |
Li WP, Lewis JS, Kim J, Bugaj JE, Johnson MA, Erion JL, Anderson CJ. DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjugate Chemistry. 13: 721-8. PMID 12121126 DOI: 10.1021/Bc015590K |
0.508 |
|
| 2002 |
Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Journal of Medicinal Chemistry. 45: 469-77. PMID 11784151 DOI: 10.1021/Jm0103817 |
0.789 |
|
| 2001 |
Lewis MR, Boswell CA, Laforest R, Buettner TL, Ye D, Connett JM, Anderson CJ. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3. Cancer Biotherapy & Radiopharmaceuticals. 16: 483-94. PMID 11789025 DOI: 10.1089/10849780152752083 |
0.722 |
|
| 2001 |
Anderson CJ. Metabolism of radiometal-labeled proteins and peptides: What are the real radiopharmaceuticals in vivo? Cancer Biotherapy and Radiopharmaceuticals. 16: 451-455. PMID 11789022 DOI: 10.1089/10849780152752056 |
0.435 |
|
| 2001 |
Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ. Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model International Journal of Cancer. 94: 873-877. PMID 11745491 DOI: 10.1002/Ijc.1540 |
0.305 |
|
| 2001 |
Edwards WB, Anderson CJ, Fields GB, Welch MJ. Evaluation of radiolabeled type IV collagen fragments as potential tumor imaging agents. Bioconjugate Chemistry. 12: 1057-65. PMID 11716700 DOI: 10.1021/Bc015520D |
0.526 |
|
| 2001 |
Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, Lewis JS, McCarthy DW. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 213-21. PMID 11216519 |
0.359 |
|
| 2001 |
Li WP, Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Copper-64/61 and iodine-125-labeled dota-DTYR1-octreotate: A new somatostatin analog for labeling with metals and halogens Journal of Labelled Compounds and Radiopharmaceuticals. 44: S948-S950. DOI: 10.1002/Jlcr.25804401333 |
0.353 |
|
| 2001 |
Sun X, Anderson CJ, Wuest M, Welch MJ, Peng Y, Weisman GR, Wong EH. Copper-64 radiolabeling and in vivo behavior of 4, 11-bis(carboxymethyl)-1, 4, 8, 11-tetraazabicyclo[6.6.2]hexadecane Journal of Labelled Compounds and Radiopharmaceuticals. 44: S784-S786. DOI: 10.1002/Jlcr.25804401276 |
0.524 |
|
| 2001 |
Sun X, Wuest M, Kovacs Z, Sherry AD, Anderson CJ, Welch MJ. The in vivo evaluation of copper-64 radiolabeled DO2P, DO3P, and DOTP complexes Journal of Labelled Compounds and Radiopharmaceuticals. 44: S781-S783. DOI: 10.1002/Jlcr.25804401275 |
0.555 |
|
| 2001 |
Boswell CA, Sun X, Wang M, Ramos B, Weisman GR, Wong EH, Anderson CJ. Relationship between reduction potential and in vivo stability of copper-azamacrocycle complexes Journal of Labelled Compounds and Radiopharmaceuticals. 44: S770-S772. DOI: 10.1002/Jlcr.25804401271 |
0.681 |
|
| 2001 |
Chen X, Edwards WB, Anderson CJ, Mccarthy TJ, Welch MJ. Solid phase synthesis of teta conjugated vasoactive intestinal peptide and in vivo behavior of copper-64 radiolabeled vip conjugate Journal of Labelled Compounds and Radiopharmaceuticals. 44: S688-S690. DOI: 10.1002/Jlcr.25804401243 |
0.486 |
|
| 2000 |
Lewis JS, Laforest R, Lewis MR, Anderson CJ. Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model. Cancer Biotherapy & Radiopharmaceuticals. 15: 593-604. PMID 11190491 DOI: 10.1089/Cbr.2000.15.593 |
0.402 |
|
| 2000 |
Blankenberg FG, Eckelman WC, Strauss HW, Welch MJ, Alavi A, Anderson C, Bacharach S, Blasberg RG, Graham MM, Weber W. Role of radionuclide imaging in trials of antiangiogenic therapy Academic Radiology. 7: 851-867. PMID 11048882 DOI: 10.1016/S1076-6332(00)80633-9 |
0.5 |
|
| 2000 |
Cutler CS, Wuest M, Anderson CJ, Reichert DE, Sun Y, Martell AE, Welch MJ. Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes. Nuclear Medicine and Biology. 27: 375-80. PMID 10938473 DOI: 10.1016/S0969-8051(00)00101-3 |
0.665 |
|
| 2000 |
Bass LA, Wang M, Welch MJ, Anderson CJ. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chemistry. 11: 527-32. PMID 10898574 DOI: 10.1021/Bc990167L |
0.638 |
|
| 1999 |
Anderson CJ, Welch MJ. Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chemical Reviews. 99: 2219-34. PMID 11749480 DOI: 10.1021/Cr980451Q |
0.46 |
|
| 1999 |
McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ. High purity production and potential applications of copper-60 and copper-61. Nuclear Medicine and Biology. 26: 351-8. PMID 10382836 DOI: 10.1016/S0969-8051(98)00113-9 |
0.66 |
|
| 1999 |
Cutler CS, Giron MC, Reichert DE, Snyder AZ, Herrero P, Anderson CJ, Quarless DA, Koch SA, Welch MJ. Evaluation of gallium-68 tris(2-mercaptobenzyl)amine: a complex with brain and myocardial uptake. Nuclear Medicine and Biology. 26: 305-16. PMID 10363802 DOI: 10.1016/S0969-8051(98)00108-5 |
0.456 |
|
| 1999 |
Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake. Nuclear Medicine and Biology. 26: 267-73. PMID 10363797 DOI: 10.1016/S0969-8051(98)00105-X |
0.523 |
|
| 1999 |
Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. Journal of Medicinal Chemistry. 42: 1341-7. PMID 10212119 DOI: 10.1021/Jm980602H |
0.572 |
|
| 1999 |
Fujibayashi Y, Cutler CS, Anderson CJ, McCarthy DW, Jones LA, Sharp T, Yonekura Y, Welch MJ. Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nuclear Medicine and Biology. 26: 117-21. PMID 10096511 DOI: 10.1016/S0969-8051(98)00049-3 |
0.61 |
|
| 1999 |
Spradau TW, Edwards WB, Anderson CJ, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide. Nuclear Medicine and Biology. 26: 1-7. PMID 10096494 DOI: 10.1016/S0969-8051(98)00060-2 |
0.461 |
|
| 1999 |
Anderson CJ, Choppin GR, Pruett DJ, Costa D, Smith W. Electrochemistry and Spectroscopy of UO22+ in Addic AlCl3-EMIC Radiochimica Acta. 84. DOI: 10.1524/Ract.1999.84.1.31 |
0.406 |
|
| 1999 |
Reichert DE, Lewis JS, Anderson CJ. Metal complexes as diagnostic tools Coordination Chemistry Reviews. 184: 3-66. DOI: 10.1016/S0010-8545(98)00207-0 |
0.322 |
|
| 1998 |
Jones-Wilson TM, Deal KA, Anderson CJ, McCarthy DW, Kovacs Z, Motekaitis RJ, Sherry AD, Martell AE, Welch MJ. The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nuclear Medicine and Biology. 25: 523-30. PMID 9751418 DOI: 10.1016/S0969-8051(98)00017-1 |
0.615 |
|
| 1997 |
Downer JB, McCarthy TJ, Edwards WB, Anderson CJ, Welch MJ. Reactivity of p-[18F]fluorophenacyl bromide for radiolabeling of proteins and peptides. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 48: 907-16. PMID 9376825 DOI: 10.1016/S0969-8043(97)00012-2 |
0.432 |
|
| 1997 |
Schwarz SW, Connett JM, Anderson CJ, Rocque PA, Philpott GW, Guo LW, Welch MJ. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody. Nuclear Medicine and Biology. 21: 619-26. PMID 9234319 DOI: 10.1016/0969-8051(94)90027-2 |
0.423 |
|
| 1997 |
McCarthy DW, Shefer RE, Klinkowstein RE, Bass LA, Margeneau WH, Cutler CS, Anderson CJ, Welch MJ. Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nuclear Medicine and Biology. 24: 35-43. PMID 9080473 DOI: 10.1016/S0969-8051(96)00157-6 |
0.641 |
|
| 1996 |
Li Y, Martell AE, Hancock RD, Reibenspies JH, Anderson CJ, Welch MJ. N,N'-Ethylenedi-L-cysteine (EC) and Its Metal Complexes: Synthesis, Characterization, Crystal Structures, and Equilibrium Constants. Inorganic Chemistry. 35: 404-414. PMID 11666222 DOI: 10.1021/Ic941330L |
0.444 |
|
| 1996 |
Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjugate Chemistry. 7: 511-22. PMID 8853465 DOI: 10.1021/Bc9600372 |
0.744 |
|
| 1996 |
Herrero P, Hartman JJ, Green MA, Anderson CJ, Welch MJ, Markham J, Bergmann SR. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 37: 1294-300. PMID 8708759 |
0.527 |
|
| 1996 |
Connett JM, Anderson CJ, Guo LW, Schwarz SW, Zinn KR, Rogers BE, Siegel BA, Philpott GW, Welch MJ. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. Proceedings of the National Academy of Sciences of the United States of America. 93: 6814-8. PMID 8692901 DOI: 10.1073/Pnas.93.13.6814 |
0.765 |
|
| 1996 |
Sun Y, Anderson CJ, Pajeau TS, Reichert DE, Hancock RD, Motekaitis RJ, Martell AE, Welch MJ. Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior. Journal of Medicinal Chemistry. 39: 458-70. PMID 8558514 DOI: 10.1021/Jm9505977 |
0.46 |
|
| 1995 |
Jones-Wilson TM, Motekaitis RJ, Sun Y, Anderson CJ, Martell AE, Welch MJ. New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III). Nuclear Medicine and Biology. 22: 859-68. PMID 8547883 DOI: 10.1016/0969-8051(95)00033-T |
0.469 |
|
| 1995 |
Cutler PD, Schwarz SW, Anderson CJ, Connett JM, Welch MJ, Philpott GW, Siegel BA. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2363-71. PMID 8523133 |
0.445 |
|
| 1995 |
Anderson CJ, Pajeau TS, Edwards WB, Sherman EL, Rogers BE, Welch MJ. In vitro and in vivo evaluation of copper-64-octreotide conjugates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2315-25. PMID 8523125 |
0.551 |
|
| 1995 |
Anderson CJ, John CS, Li YJ, Hancock RD, McCarthy TJ, Martell AE, Welch MJ. N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies. Nuclear Medicine and Biology. 22: 165-73. PMID 7767309 DOI: 10.1016/0969-8051(94)00106-T |
0.454 |
|
| 1995 |
Philpott GW, Schwarz SW, Anderson CJ, Dehdashti F, Connett JM, Zinn KR, Meares CF, Cutler PD, Welch MJ, Siegel BA. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 1818-24. PMID 7562049 |
0.473 |
|
| 1995 |
Rogers BE, Franano FN, Duncan JR, Edwards WB, Anderson CJ, Connett JM, Welch MJ. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Research. 55: 5714s-5720s. PMID 7493333 |
0.376 |
|
| 1995 |
Katti KK, Singh PR, Volkert WA, Anderson CJ, Welch MJ, Hoffman T, Katti KV, Ketring AR, Wang M. Synthesis and characterization of a neutral and lipophilic Ph3PN99mTcO3 complex Applied Radiation and Isotopes. 46: 53-58. DOI: 10.1016/0969-8043(94)00083-C |
0.437 |
|
| 1994 |
Chi DY, O'Neil JP, Anderson CJ, Welch MJ, Katzenellenbogen JA. Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. Journal of Medicinal Chemistry. 37: 928-37. PMID 8151620 DOI: 10.1021/Jm00033A010 |
0.453 |
|
| 1994 |
Edwards WB, Fields CG, Anderson CJ, Pajeau TS, Welch MJ, Fields GB. Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs. Journal of Medicinal Chemistry. 37: 3749-57. PMID 7966134 DOI: 10.1021/Jm00048A011 |
0.48 |
|
| 1994 |
O'Neil JP, Carlson KE, Anderson CJ, Welch MJ, Katzenellenbogen JA. Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate. Bioconjugate Chemistry. 5: 182-93. PMID 7918738 DOI: 10.1021/Bc00027A002 |
0.479 |
|
| 1994 |
Rogers BE, Franano FN, Edwards WB, Connett JM, Anderson CJ, Duncan JR, Welch MJ. IDENTIFICATION OF METABOLITES OF IN-111-DTPA-MONOCLONAL ANTIBODIES AND ANTBODY FRAGMENTS IN VIVO Journal of Immunotherapy. 16: 165. DOI: 10.1097/00002371-199408000-00078 |
0.517 |
|
| 1993 |
Anderson CJ, Rocque PA, Weinheimer CJ, Welch MJ. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. Nuclear Medicine and Biology. 20: 461-7. PMID 8504288 DOI: 10.1016/0969-8051(93)90077-8 |
0.651 |
|
| 1993 |
Herrero P, Markham J, Weinheimer CJ, Anderson CJ, Welch MJ, Green MA, Bergmann SR. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography. Circulation. 87: 173-83. PMID 8419005 DOI: 10.1161/01.Cir.87.1.173 |
0.536 |
|
| 1991 |
Anderson CJ, Deakin MR, Choppin GR, D'Olieslager W, Heerman L, Pruett DJ. Spectroscopy and electrochemistry of U(IV)/U(III) in basic aluminum chloride-1-ethyl-3-methylimidazolium chloride Inorganic Chemistry. 30: 4013-4016. DOI: 10.1021/Ic00021A009 |
0.418 |
|
| 1989 |
Blaha SL, Anderson CJ, Choppin GR, Pruett DJ. Evaluation of POCl3 as a solvent for complexation studies Inorganica Chimica Acta. 156: 37-39. DOI: 10.1016/S0020-1693(00)90365-7 |
0.354 |
|
| Show low-probability matches. |
